Cargando…

S35. THE PLACEBO CONUNDRUM: MITIGATING THE RESPONSE AT THE SITE LEVEL

BACKGROUND: The placebo effect within Schizophrenia clinical trials has been noted as alarmingly high (Kinon et al., 2011). While numerous methodological approaches have been implemented to reduce this phenomenon (e.g., centralized ratings, remote rater monitoring, and data surveillance before subje...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hassman, Howard, Cohen, Elan, Walling, David, Wyka, Katarzyna, Grindell, Vera, Glass, Steven, Ball, Roberta, Styczynski, John, Lobb, Jaclyn, Hazzard, Dakota, Joseph, Ashok, Ereshefsky, Larry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Session I
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233954/ http://dx.doi.org/10.1093/schbul/sbaa031.101

Ejemplares similares

Placebo response mitigation with a participant-focused psychoeducational procedure: a randomized, single-blind, all placebo study in major depressive and psychotic disorders
por: Cohen, Elan A., et al.
Publicado: (2020)

S221. THE EFFICACY OF LUMATEPERONE 42 MG IN THE TREATMENT OF SCHIZOPHRENIA SYMPTOMS ASSOCIATED WITH SOCIAL FUNCTIONING: POST HOC ANALYSIS OF AN ACUTE PLACEBO- AND ACTIVE-CONTROLLED TRIAL
por: Vanover, Kimberly, et al.
Publicado: (2020)

S96. EXAMINING DIFFERENCES BETWEEN CURRENT CANNABIS CONSUMPTION AND COGNITIVE FUNCTIONING OF FIRST-EPISODE PSYCHOSIS PATIENTS: A RETROSPECTIVE STUDY
por: Pochiet, Gabrielle, et al.
Publicado: (2020)

S59. LINKING VERBAL MEMORY DEFICITS, HIPPOCAMPAL VOLUME, AND FUNCTIONING: SEX DIFFERENCES ARE CRUCIAL
por: Buck, Gabriella, et al.
Publicado: (2020)

S147. FUNCTIONAL BRAIN CONNECTIVITY DATA IMPROVE CLINICAL OUTCOME PREDICTION IN YOUTH AT RISK FOR PSYCHOSIS
por: Collin, Guusje, et al.
Publicado: (2020)

S173. GENOME-WIDE ASSOCIATION STUDIES OF SCHIZOPHRENIA AND BIPOLAR DISORDER IN A DIVERSE COHORT OF US VETERANS
por: Bigdeli, Tim, et al.
Publicado: (2020)

S49. THE RELATION BETWEEN PROCESSING SPEED AND USAGE OF MOBILE APPLICATIONS IN PATIENTS WITH SCHIZOPHRENIA
por: Hoşgelen, Emine Ilgın, et al.
Publicado: (2020)

S29. ONE-CARBON METABOLISM AND STRESS IN CHILDREN AND ADOLESCENTS WITH PSYCHOSIS RISK SYNDROME: PRELIMINARY DATA
por: Baeza, Inmaculada, et al.
Publicado: (2020)

S17. GLOBAL DNA METHYLATION IN CURRENT AND EMERGENT SUICIDAL IDEATION: ANALYSIS IN SCHIZOPHRENIA
por: Bani-Fatemi, Ali, et al.
Publicado: (2020)

S14. ANALYSIS OF METHYLATION AGE AND BLOOD CELL COMPOSITION IN SUBJECTS WITH CURRENT SUICIDE IDEATION
por: Dada, Oluwagbenga, et al.
Publicado: (2020)

S234. DEPRESSION AND SEXUAL FUNCTIONING: TWO NEGLECTED AND PREVALENT DOMAINS IN PEOPLE WITH SCHIZOPHRENIA
por: Lapa, Clara, et al.
Publicado: (2020)

S61. COMPUTATIONAL MODELLING OF VISUAL MOTION PERCEPTION AND ITS ASSOCIATION WITH SCHIZOTYPAL TRAITS
por: Farkas, Kinga, et al.
Publicado: (2020)

S11. PLASMA LEPTIN AND ANTHRANILIC ACID IN SCHIZOPHRENIA PATIENTS: NEW BIOMARKERS OF PREDISPOSITION TO METABOLIC ABNORMALITIES
por: Steiner, Johann, et al.
Publicado: (2020)

S52. SPATIAL MEMORY DEFICITS IN SCHIZOPHRENIA: NEUROLOGICAL SOFT SIGNS DIFFERENTIALLY INFLUENCE PERFORMANCES IN 3-D VIRTUAL VERSUS TACTILE RECOGNITION TASKS
por: Abichou, Kouloud, et al.
Publicado: (2020)

S34. EFFECTIVENESS OF INDIVIDUAL METACOGNITIVE TRAINING (MCT+) IN FIRST-EPISODE PSYCHOSIS
por: Ochoa, Susana, et al.
Publicado: (2020)

S224. TREATMENT IN THE PSYCHOSIS FIRST EPISODE PROGRAM “ZüRCHER ERSTPSYCHOSEN NETZWERK (ZEN)”: QUALITY CONTROL OF THE OUTCOME
por: Metzler, Sibylle, et al.
Publicado: (2020)

S68. DIFFERENTIAL PATTERN OF SOCIAL COGNITION IMPAIRMENT BETWEEN RURAL AND URBAN DWELLING PATIENTS OF SCHIZOPHRENIA AND ITS FUNCTIONAL CORRELATES
por: Ibrahim, Ferose, et al.
Publicado: (2020)

S43. ASSESSING THE VARIABILITY OF RESPONSE TO NON-INVASIVE BRAIN STIMULATION IN PSYCHOSIS
por: Winkelbeiner, Stephanie, et al.
Publicado: (2020)

S67. TREATMENT-RESISTANCE AFFECTS LONG-TERM COGNITIVE TRAJECTORIES IN SCHIZOPHRENIA: A LONGITUDINAL STUDY
por: Spangaro, Marco, et al.
Publicado: (2020)

S22. SPECIFIC PSYCHOTIC EXPERIENCES AND DEPRESSIVE SYMPTOMS IN CHILEAN ADOLESCENTS: A MULTIPLE MEDIATION MODEL OF THEIR IMPACT ON SUICIDAL IDEATION
por: Nunez, Daniel, et al.
Publicado: (2020)

S24. PATHWAYS LINKING ENVIRONMENTAL RISKS, POLYGENIC RISK SCORE TO SCHIZOPHRENIA AND PSYCHOTIC EXPERIENCES IN A BRAZILIAN COHORT OF CHILDREN AND ADOLESCENTS
por: Fonseca, Lais, et al.
Publicado: (2020)

S31. ENHANCEMENT OF SYNAPTIC PLASTICITY BY COMBINATION OF PDE2 AND PDE9 INHIBITION PRESUMABLY VIA PRE- AND POST-SYNAPTIC MECHANISMS
por: Rosenbrock, Holger, et al.
Publicado: (2020)

S64. COGNITIVE IMPAIRMENTS AND PREDICTION OF FUNCTIONAL OUTCOME IN INDIVIDUALS AT CLINICAL HIGH-RISK FOR PSYCHOSIS
por: Haining, Kate, et al.
Publicado: (2020)

S48. INSIGHT VS COGNITION AND SYMPTOMATIC REMISSION AMONG PATIENTS WITH SCHIZOPHRENIA- THE INFLUENCE OF TRAIT VS STATE PHENOMENON?
por: Helldin, Lars, et al.
Publicado: (2020)

S10. SCREENING FOR ANTI-NMDAR ANTIBODIES AMONGST PATIENTS WITH FIRST EPISODE PSYCHOSIS
por: Herman, Levente, et al.
Publicado: (2020)

S56. SWITCHING FROM RISPERIDONE TO PALIPERIDONE PALMITATE IN SCHIZOPHRENIA: CHANGES IN COGNITIVE FUNCTION
por: Tost Bonet, Meritxell, et al.
Publicado: (2020)

S44. NEUROBIOLOGICAL FINGERPRINTS OF COGNITIVE SUBTYPES IN RECENT ONSET PSYCHOSIS PATIENTS
por: Wenzel, Julian, et al.
Publicado: (2020)

S79. REINFORCEMENT LEARNING ABNORMALITIES IN INDIVIDUALS AT CLINICAL HIGH RISK AND IN THE FIRST EPISODE OF PSYCHOSIS
por: Datta, Raktima, et al.
Publicado: (2020)

S228. SOCIAL AND OCCUPATIONAL FUNCTIONING AND SATISFACTION WITH CARE IN FINNISH FIRST-EPISODE PSYCHOSIS PATIENTS
por: Barrientos, Paula, et al.
Publicado: (2020)

S232. ASSOCIATIONS OF FOOD CRAVING WITH PSYCHOLOGICAL AND PHYSICAL CHARACTERISTICS IN PATIENTS WITH FIRST-EPISODE PSYCHOSIS
por: Kim, Yeonghyeok, et al.
Publicado: (2020)

S239. EVALUATION OF A POINT OF CARE DEVICE IN IMPROVING PHYSICAL HEALTH CHECK UPTAKE IN TWO COMMUNITY MENTAL HEALTH TEAMS
por: Butler, Joseph, et al.
Publicado: (2020)

S9. NEUROIMAGING AND NEUROPHYSIOLOGY BIOMARKERS OF SCHIZOTYPAL PERSONALITY DISORDER: A SYSTEMATIC REVIEW
por: Attademo, Luigi, et al.
Publicado: (2020)

S81. METAMEMORY IMPAIRMENT ACROSS THE PSYCHOSIS TRAJECTORY: ASSOCIATIONS WITH SYMPTOM SEVERITY
por: Seabury, Rashina, et al.
Publicado: (2020)

S30. SCHIZOPHRENIA IN A FISH: EFFECTS OF NMDA ANTAGONISM ON LOCOMOTOR BEHAVIOR AND SOCIAL INTERACTION IN ZEBRAFISH
por: Gallas-Lopes, Matheus, et al.
Publicado: (2020)

S25. FRAMEWORK FOR THE CHARACTERIZATION OF HIPPOCAMPUS USING RADIOMIC APPROACH IN FIRST-EPISODE PSYCHOSIS
por: Masias, Mireia, et al.
Publicado: (2020)

S53. DELINEATING SOCIAL COGNITION IN AUTISM AND PSYCHOSIS
por: Ziermans, Tim, et al.
Publicado: (2020)

S74. AEROBIC EXERCISE AND COGNITIVE REMEDIATION IN MULTIEPISODE SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER: PRELIMINARY RESULTS: FROM A RANDOMIZED CLINICAL TRIAL
por: Pujol, Nuria, et al.
Publicado: (2020)

S73. RELATIONSHIP OF COGNITIVE ABILITY AND PERSONALITY TRAITS WITH HOSTILE ATTRIBUTION BIAS IN NONCLINICAL SUBJECTS: THEORY OF MIND AS A MEDIATOR
por: Jun Koo, Se, et al.
Publicado: (2020)

S32. ARE SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS POTENTIAL THERAPEUTICS FOR SCHIZOPHRENIA?
por: Breier, Alan, et al.
Publicado: (2020)

S121. OPUS 20, 20 YEAR FOLLOW-UP ON THE OPUS TRIAL
por: Starzer, Marie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fd8h17419utdg5vcdrrtm0dnmb